{"id":2356,"date":"2025-10-15T05:09:00","date_gmt":"2025-10-15T05:09:00","guid":{"rendered":"https:\/\/www.karongrilli.fi\/?p=2356"},"modified":"2025-10-15T05:19:59","modified_gmt":"2025-10-15T05:19:59","slug":"mahdollisuus-miljardeihin-herantis-pharman-antti-vuolanto","status":"publish","type":"post","link":"http:\/\/www.karongrilli.fi\/?p=2356","title":{"rendered":"Mahdollisuus miljardeihin, Herantis Pharman Antti Vuolanto?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><em>Herantis Pharmalla<\/em> saattaa olla k\u00e4siss\u00e4\u00e4n molekyyli, joka hidastaa Parkinsonin taudin etenemist\u00e4 tai jopa pys\u00e4ytt\u00e4\u00e4 sen. Se olisi mullistavaa, sill\u00e4 t\u00e4ll\u00e4 hetkell\u00e4 markkinoilla olevat Parkinsonin taudin l\u00e4\u00e4kkeet hoitavat vain oireita, eiv\u00e4t vaikuta taudinkulkuun.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Jos <em>Herantiksen <\/em>HER-096 tepsii toivotusti, sill\u00e4 pit\u00e4isi olla hyv\u00e4t mahdollisuudet kahmaista iso siivu Parkinsonin taudin l\u00e4\u00e4kemarkkinasta, jonka arvioidaan kasvavan ensi vuosikymmenen alkupuolella kymmeneen miljardiin euroon.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">HER-096 on juuri k\u00e4ynyt l\u00e4pi 1b-vaiheen tutkimukset, joissa varmistuttiin molekyylin turvallisuudesta ja siedett\u00e4vyydest\u00e4. Tehoa ryhdyt\u00e4\u00e4n tutkimaan vaiheessa 2, joka alkanee vuonna 2026.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sit\u00e4 ennen <em>Herantis <\/em>pyrkii kuitenkin l\u00f6yt\u00e4m\u00e4\u00e4n kumppanikseen suuren l\u00e4\u00e4keyhti\u00f6n, joka ottaisi l\u00e4\u00e4kkeen jatkokehityksen hoteisiinsa, tai ainakin rahoitettavakseen.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201dJos katsotaan hermorappeumasairauksia, aika usein t\u00e4ss\u00e4 vaiheessa kliinisess\u00e4 kehityksess\u00e4 [olevien l\u00e4\u00e4kkeiden] sopimuksiin monesti kuuluu ihan merkitt\u00e4v\u00e4 allekirjoitusmaksu. Puhutaan kymmenist\u00e4 miljoonista, ellei enemm\u00e4nkin. Tyypillisesti alalla virstanpylv\u00e4smaksut ovat miljardin kieppeill\u00e4\u201d, <em>Herantis Pharman <\/em>toimitusjohtaja <strong>Antti Vuolanto<\/strong> kuvailee Karon Grilliss\u00e4.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\nhttps:\/\/youtu.be\/zvh2Ra_ZGhA\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Herantis Pharmalla saattaa olla k\u00e4siss\u00e4\u00e4n molekyyli, joka hidastaa Parkinsonin taudin etenemist\u00e4 tai jopa pys\u00e4ytt\u00e4\u00e4 sen. Se olisi mullistavaa, sill\u00e4 t\u00e4ll\u00e4 hetkell\u00e4 markkinoilla olevat Parkinsonin taudin l\u00e4\u00e4kkeet hoitavat vain oireita, eiv\u00e4t vaikuta taudinkulkuun. Jos Herantiksen HER-096 tepsii toivotusti, sill\u00e4 pit\u00e4isi olla hyv\u00e4t mahdollisuudet kahmaista iso siivu Parkinsonin taudin l\u00e4\u00e4kemarkkinasta, jonka arvioidaan kasvavan ensi vuosikymmenen alkupuolella kymmeneen [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":2357,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[36],"tags":[169,168,96],"class_list":["post-2356","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-grillit","tag-antti-vuolanto","tag-herantis-pharma","tag-laakekehitys"],"uagb_featured_image_src":{"full":["http:\/\/www.karongrilli.fi\/wp-content\/uploads\/2025\/10\/251015-Antti-Vuolanto-sinappi.jpg",1920,1080,false],"thumbnail":["http:\/\/www.karongrilli.fi\/wp-content\/uploads\/2025\/10\/251015-Antti-Vuolanto-sinappi-150x150.jpg",150,150,true],"medium":["http:\/\/www.karongrilli.fi\/wp-content\/uploads\/2025\/10\/251015-Antti-Vuolanto-sinappi-300x169.jpg",300,169,true],"medium_large":["http:\/\/www.karongrilli.fi\/wp-content\/uploads\/2025\/10\/251015-Antti-Vuolanto-sinappi-768x432.jpg",768,432,true],"large":["http:\/\/www.karongrilli.fi\/wp-content\/uploads\/2025\/10\/251015-Antti-Vuolanto-sinappi-1024x576.jpg",1024,576,true],"1536x1536":["http:\/\/www.karongrilli.fi\/wp-content\/uploads\/2025\/10\/251015-Antti-Vuolanto-sinappi-1536x864.jpg",1536,864,true],"2048x2048":["http:\/\/www.karongrilli.fi\/wp-content\/uploads\/2025\/10\/251015-Antti-Vuolanto-sinappi.jpg",1920,1080,false],"mailpoet_newsletter_max":["http:\/\/www.karongrilli.fi\/wp-content\/uploads\/2025\/10\/251015-Antti-Vuolanto-sinappi-1320x743.jpg",1320,743,true]},"uagb_author_info":{"display_name":"Karo H\u00e4m\u00e4l\u00e4inen","author_link":"http:\/\/www.karongrilli.fi\/?author=2"},"uagb_comment_info":0,"uagb_excerpt":"Herantis Pharmalla saattaa olla k\u00e4siss\u00e4\u00e4n molekyyli, joka hidastaa Parkinsonin taudin etenemist\u00e4 tai jopa pys\u00e4ytt\u00e4\u00e4 sen. Se olisi mullistavaa, sill\u00e4 t\u00e4ll\u00e4 hetkell\u00e4 markkinoilla olevat Parkinsonin taudin l\u00e4\u00e4kkeet hoitavat vain oireita, eiv\u00e4t vaikuta taudinkulkuun. Jos Herantiksen HER-096 tepsii toivotusti, sill\u00e4 pit\u00e4isi olla hyv\u00e4t mahdollisuudet kahmaista iso siivu Parkinsonin taudin l\u00e4\u00e4kemarkkinasta, jonka arvioidaan kasvavan ensi vuosikymmenen alkupuolella kymmeneen&hellip;","_links":{"self":[{"href":"http:\/\/www.karongrilli.fi\/index.php?rest_route=\/wp\/v2\/posts\/2356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.karongrilli.fi\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.karongrilli.fi\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.karongrilli.fi\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/www.karongrilli.fi\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2356"}],"version-history":[{"count":2,"href":"http:\/\/www.karongrilli.fi\/index.php?rest_route=\/wp\/v2\/posts\/2356\/revisions"}],"predecessor-version":[{"id":2359,"href":"http:\/\/www.karongrilli.fi\/index.php?rest_route=\/wp\/v2\/posts\/2356\/revisions\/2359"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.karongrilli.fi\/index.php?rest_route=\/wp\/v2\/media\/2357"}],"wp:attachment":[{"href":"http:\/\/www.karongrilli.fi\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2356"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.karongrilli.fi\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2356"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.karongrilli.fi\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}